(NEW YORK)– ChineseInvestors.com, Inc. (OTCQB: CIIX) announced Q2 revenues increased 43% to $648,265, with Hemp and CBD sales revenues increased 8x, year-over-year.
Q2 Financial Highlights
– Year-over-Year total revenue increased 50%+
– Hemp and CBD sales revenues increased 8x, year-over-year
– Subscription revenues increased over 40%, year-over-year
ChineseInvestors.com reported Q2FY2019 Revenues of $648,265, a 43% increase year over year. This increase was driven by stronger subscription revenues and Hemp/CBD sales revenues.
The Company’s introduction of new Hemp/CBD products and focused, effective marketing efforts increased Hemp/CBD sales revenues over eight times to over $430,000.
“We are beginning to see the positive results of investments made into existing markets as well as new markets,” says Warren Wang, the Company’s CEO. “We believe our investors will benefit from the growth drivers that we have worked diligently to implement, including the recent launch of CBD Biotechnology Co. Ltd.’s Hemp Wine. As we leverage the momentum already in place, we look forward to having an even stronger second half for FY 2019,” says Mr. Wang.
CBD Infused Beverage Market
CIIX trades within the CBD infused beverage market, which has been seeing high interest among retail traders. Some of other players in the CBD Infused beverage market include New Age Beverages (NASDAQ:NBEV), American Premium Water (OTC:HIPH), India Globalization Capital (OTC:IGCC), Real Brands (OTC:RLBD), and Puration (OTC:PURA) just to name a few.
The Company’s complete financial and operational results for its second quarter ended November 30, 2018 is provided in its Form 10Q for Q2 FY2019, filed with the SEC on January 14, 2019, available online at http://www.ChineseInvestors.com
About ChineseInvestors.com (OTCQB: CIIX)
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online and direct sales of hemp-based products and other health related products. For more information visit ChineseInvestors.com
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom
Follow them on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh
Like them on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom
Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.
227 W. Valley Blvd, #208 A
San Gabriel, CA 91776
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was compensated two thousand five hundred dollars by company for ongoing media advisory services, and thus should be considered a possible conflict of interest when reviewing this report and information. WSNC, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial adviser before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial adviser before making any and all investment decisions when investing in these type of securities
- 4 Face Mask Stocks to Trade in COVID-19 Outbreak - July 22, 2020
- Dynavax (DVAX) Receives $27M Vaccine Purchase Order from CDC - July 1, 2020
- As COVID-19 Cases Spike Look to PPE Stocks: $LAKE $APT $GTXO - June 15, 2020
- Spike in COVID Cases May Spell Risk Off for Overvalued Stocks and Markets - June 7, 2020
- Riot Blockchain (RIOT) a Hedge on Inflation as Bitcoin Rallies - May 13, 2020
- Stock Valuations Could Set Stage for Potential Bubble Burst - May 9, 2020
- Centennial Resource (CDEV) Boosts Liquidity $468M as WTI Crude Breaks Above $20 Barrel - May 4, 2020
- Companies Should Prepare IT Spending to Thrive in New Normal - April 16, 2020
- Great Elm Capital (GEC) Provides Ventilators and Respiratory Care Equipment - April 15, 2020
- FujiFilm (FUJIY) to Ramp Up Production of Avigan for Treatment of COVID19 - April 15, 2020